Evaluation of out-patient rehabilitation measures of persisting symptoms caused by a COVID-19 infection (post-COVID) in health care workers

Organizational Data

DRKS-ID:
DRKS00033651
Recruitment Status:
Recruiting ongoing
Date of registration in DRKS:
2024-02-15
Last update in DRKS:
2024-04-17
Registration type:
Prospective

Acronym/abbreviation of the study

No Entry

URL of the study

No Entry

Brief summary in lay language

In a longitudinal study, insured people of the institution for statutory accident insurance and prevention in the health and welfare services (BGW) are receiving a questionnaire concerning their symptoms, their state of health and the rehabilitation measures at three points of time. The first will be before the start and the second time point will be after completing their rehabilitation measure in out-patient care. To observe the sustainability of the rehabilitation measures, they will be contacted a third time three months after completing the rehabilitation.

Brief summary in scientific language

In a quantitative longitudinal study, insured people of the institution for statutory accident insurance and prevention in the health and welfare services (BGW) are contacted via paper-pencil questionnaire to give information about their symptoms, health-related quality of life and the rehabilitation measures in the stationary and out-patient setting. The study has three measuring point with the first two following a pre-post-design for the out-patient rehabilitation measure and the third time point evaluating the sustainability of the effects by conducting a three-months-follow-up measuring. Additionally, it is planned to conduct focus group interviews with providers of post-COVID rehabilitation.

Health condition or problem studied

ICD10:
U09.9 - Post COVID-19 condition, unspecified
Healthy volunteers:
No

Interventions, Observational Groups

Arm 1:
Cases, who receive/will receive/have received an out-patient rehabilitation measure because of a COVID-19 disease. These people receive a quantitative survey at three different measurement points (before and after the out-patient rehabilitation measure, as well as three months after the second measurement) about their symptoms, health-related quality of life and the rehabilitation measure.

Endpoints

Primary outcome:
patient-reported post-COVID symptoms measured with the standardised Post-COVID syndrome score (PCS Score) developed by Bahmer et al. (compare: Bahmer, T., et al., Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. eClinicalMedicine, 2022. 51: p. 101549). This instruments includes 12 symptoms that are often reported by patients suffering from PCS. Those symptoms are weighted and summed up in an overall score indicating the severity of their PCS. The score is divided in three categories (no/mild PCS, moderate PCS and severe PCS). This instrument will be used in all three surveys (before and after the out-patient rehabilitation measure, as well as three months after the second measurement).
Secondary outcome:
Health-related quality of life measured with SF-12; this instrument shows using two scores the mental and physical quality of life. Also this instrument will be used in all three surveys.

Study Design

Purpose:
Treatment
Retrospective/prospective:
Both
Study type:
Non-interventional
Longitudinal/cross-sectional:
Longitudinal study
Study type non-interventional:
No Entry

Recruitment

Recruitment Status:
Recruiting ongoing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • University medical center Universitätsklinikum Hamburg-Eppendorf Hamburg

Recruitment period and number of participants

Planned study start date:
2024-03-11
Actual study start date:
2024-04-12
Planned study completion date:
2025-12-31
Actual Study Completion Date:
No Entry
Target Sample Size:
120
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
persisting symptoms after COVID-19 infection (post-COVID) a registered (at BGW) stationary and/or out-patient rehabilitation measure because of COVID-19

Exclusion Criteria

People, who were already contacted and/or surveyed by the BGW for another study on COVID-19 people, whose out-patient rehabilitation has been registered before January 2023

Addresses

Primary Sponsor

Address:
Universitätsklinikum Hamburg-Eppendorf
Prof. Dr. Uwe Koch-Gromus
Martinistr. 52
20246 Hamburg
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Universitätsklinikum Hamburg-Eppendorf
Prof. Dr. Uwe Koch-Gromus
Martinistraße 52
20246 Hamburg
Germany
Telephone:
040741054132
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Contact for Public Queries

Address:
Universitätsklinikum Hamburg-Eppendorf
Svenja Mertens
Martinistraße 52
20246 Hamburg
Germany
Telephone:
01734446484
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Principal Investigator

Address:
Universitätsklinikum Hamburg-Eppendorf
Prof. Dr. Uwe Koch-Gromus
Martinistraße 52
20246 Hamburg
Germany
Telephone:
040741054132
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)

Address:
Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege
22089 Hamburg
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Lokale Psychologische Ethikkommission am Zentrum für Psychosoziale Medizin (LPEK)
Martinistraße 51
20246 Hamburg
Germany
Telephone:
+49 40 7410 0
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2024-01-31
Ethics committee number:
LPEK-0720
Vote of the Ethics Committee:
Approved
Date of the vote:
2024-02-11

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
Studienprotokoll
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
2025
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry